EARLY ONSET ALZHEIMER DISEASE
Clinical trials for EARLY ONSET ALZHEIMER DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ONSET ALZHEIMER DISEASE trials appear
Sign up with your email to follow new studies for EARLY ONSET ALZHEIMER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New spinal injection aims to slow Early-Onset Alzheimer's
Disease control Recruiting nowThis early-stage study is testing a new drug called ALN-APP for people with early-onset Alzheimer's disease. The drug is given as a shot into the spine to see if it is safe and how it affects the body. About 60 adults with mild memory problems or mild dementia will take part. The…
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Phase: PHASE1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Major study aims to unlock secrets of Early-Onset Alzheimer's
Knowledge-focused Recruiting nowThis study follows 850 people aged 40-64 with early-onset cognitive impairment to understand how Alzheimer's disease progresses. Participants undergo cognitive tests, brain scans, and genetic analysis over time. The goal is to gather data, not to test a treatment, so there is no …
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 17, 2026 03:23 UTC